Skip to content

IFPMA Twitter
IFPMA LinkedIn
IFPMA Youtube
IFPMA Slideshare
IFPMA Flickr
IFPMA RSS

Search for:

Who We Are
Topics
News Center
Resources
Events
- Upcoming IFPMA Events
- Past IFPMA Events
Partners
BCR

Inventing Medicines and Vaccines
Strengthening Regulatory Systems
Ethics and Business Integrity
Boosting Innovation and Access
Tackling Global health challenges

Climate change Economic footprint IP Sustainable innovation Value of innovation

spotlight

Value of innovation

Inventing Medicines and Vaccines

African Medicines Agency Biosimilars Biotherapeutic medicines Falsified medicines Import testing Pharmacovigilance Quality, safety, and efficacy Regulatory conferences Regulatory system strengthening / Harmonization Supply chain The Africa Regulatory Network (ARN) The ARN: Le réseau africain de réglementation pharmaceutique

spotlight

Pharmacovigilance

Strengthening Regulatory Systems

IFPMA Code of Practice (2019) Our Ethos in Action Our Ethos Code eLearning Tool IFPMA Notes for Guidance IFPMA Complaint Operating Procedure How to File a Code Complaint Complaint Submission Form Cases Business Ethics for APEC SMEs Initiative Consensus Framework for Ethical Collaboration

spotlight

IFPMA Code of Practice (2019)

Ethics and Business Integrity

Access to medicines Global Policy Principles on Digital Health Health technology assessment IP Technology Transfer Trade

spotlight

Access to medicines

Boosting Innovation and Access

Ageing Antimicrobial resistance Cancer Child and maternal health COVID-19 Diabetes Ebola Falsified medicines HIV/AIDS Influenza Malaria Mental and neurological disorders Neglected tropical diseases Non-communicable diseases Pandemic Preparedness Public health implications of the implementation of the Nagoya Protocol Rare diseases Supply chain Sustainable development goals Tuberculosis Universal Health Coverage Vaccination confidence Vaccines innovation Vaccines protect communities Vaccines sustainability Value of immunization Viral hepatitis

spotlight

Universal Health Coverage

Tackling Global health challenges

Home
>
Resources
>
Infographics
>
R&D pipeline for malaria

R&D pipeline for malaria

Published on: 23 April 2015

IFPMA_Malaria_RandD_Pipeline

Downloads

» Infographic

Resources

Case study: Malaria

Publications

Case study: Malaria

Ending neglected tropical diseases 2012 IFPMA member companies support eliminating and controlling neglected tropical diseases over the next decade through landmark donations

Publications

Ending neglected tropical diseases 2012 IFPMA member companies support eliminating and controlling neglected tropical diseases over the next decade through landmark donations

Partners in the fight against malaria: Efforts of the R&D Pharmaceutical Industry

Infographics

Partners in the fight against malaria: Efforts of the R&D Pharmaceutical Industry

Research-based pharmaceutical industry’s 360-degree efforts to fight neglected tropical diseases (NTDs)

Infographics

Research-based pharmaceutical industry’s 360-degree efforts to fight neglected tropical diseases (NTDs)

Partners in the fight against malaria: doing our part

Infographics

Partners in the fight against malaria: doing our part

R&D pipeline for malaria

Infographics

R&D pipeline for malaria

Related Blog Entries

Fake Medicines – a Hurdle on our Way to Beating Malaria

Fake Medicines – a Hurdle on our Way to Beating Malaria

Together, Taking on Drug Resistant Malaria

Together, Taking on Drug Resistant Malaria

Related Topics

Malaria

Neglected tropical diseases

Tags

Global Health
Global systems
Malaria
NTDs
R&D

Chemin des Mines 9
1202 Geneva
Switzerland

+41 22 338 32 00
info@ifpma.org

File a Code Complaint
Privacy Policy
Terms of Use
Access to Our Extranet
Careers
Contact Us

IFPMA Twitter
IFPMA LinkedIn
IFPMA Youtube
IFPMA Slideshare
IFPMA Flickr
IFPMA RSS

Designed and Produced by ACW